ATE255578T1 - Piperazin- und piperidinverbindungen - Google Patents

Piperazin- und piperidinverbindungen

Info

Publication number
ATE255578T1
ATE255578T1 AT01938214T AT01938214T ATE255578T1 AT E255578 T1 ATE255578 T1 AT E255578T1 AT 01938214 T AT01938214 T AT 01938214T AT 01938214 T AT01938214 T AT 01938214T AT E255578 T1 ATE255578 T1 AT E255578T1
Authority
AT
Austria
Prior art keywords
piperazine
piperidine compounds
piperidine
compounds
Prior art date
Application number
AT01938214T
Other languages
English (en)
Inventor
Roelof W Feenstra
Der Heijden Johannes A M Van
Cornelis G Kruse
Stephen K Long
Scharrenburg Gustaaf J M Van
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Application granted granted Critical
Publication of ATE255578T1 publication Critical patent/ATE255578T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT01938214T 2000-05-12 2001-05-10 Piperazin- und piperidinverbindungen ATE255578T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201699 2000-05-12
PCT/EP2001/005320 WO2001085725A1 (en) 2000-05-12 2001-05-10 Piperazine and piperidine compounds

Publications (1)

Publication Number Publication Date
ATE255578T1 true ATE255578T1 (de) 2003-12-15

Family

ID=8171488

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01938214T ATE255578T1 (de) 2000-05-12 2001-05-10 Piperazin- und piperidinverbindungen

Country Status (28)

Country Link
US (2) US6911448B2 (de)
EP (1) EP1283838B1 (de)
JP (1) JP2003532729A (de)
CN (1) CN1174979C (de)
AR (1) AR028443A1 (de)
AT (1) ATE255578T1 (de)
AU (2) AU6392701A (de)
BR (1) BR0110592A (de)
CA (1) CA2405971C (de)
CZ (1) CZ301464B6 (de)
DE (1) DE60101386T2 (de)
DK (1) DK1283838T3 (de)
DZ (1) DZ3370A1 (de)
ES (1) ES2211809T3 (de)
HK (1) HK1055952A1 (de)
HU (1) HUP0302016A2 (de)
IL (2) IL152177A0 (de)
MX (1) MXPA02011084A (de)
NO (1) NO323778B1 (de)
NZ (1) NZ522116A (de)
PL (1) PL198857B1 (de)
PT (1) PT1283838E (de)
RU (1) RU2261250C2 (de)
SK (1) SK286778B6 (de)
TR (1) TR200302294T4 (de)
UA (1) UA72337C2 (de)
WO (1) WO2001085725A1 (de)
ZA (1) ZA200208537B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2261250C2 (ru) * 2000-05-12 2005-09-27 Солвей Фармасьютикалс Б.В. Соединения пиперазина и пиперидина
ATE424825T1 (de) 2001-07-20 2009-03-15 Psychogenics Inc Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
AU2003244160A1 (en) * 2002-06-25 2004-01-06 Sumitomo Pharmaceuticals Co., Ltd. Novel benzoxazolinone derivative
ES2232292B1 (es) * 2003-07-30 2006-11-01 Laboratorios Del Dr. Esteve, S.A. Compuestos sulfonamidicos derivados de benzoxazinona, su preparacion y uso como medicamentos.
US7596407B2 (en) 2004-03-26 2009-09-29 Solvay Pharmaceuticals, B.V. Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
EP1595542A1 (de) * 2004-03-26 2005-11-16 Solvay Pharmaceuticals B.V. Transdermale iontophoretische Verabreichung von Piperazinyl-2(3H)-benzoxazolon-Verbindungen
PL1919883T3 (pl) * 2005-08-22 2009-06-30 Solvay Pharm Bv N-TLENKI JAKO PROLEKI PIPERAZYNOWYCH oraz PIPERYDYNOWYCH POCHODNYCH
AR058022A1 (es) * 2005-08-22 2008-01-23 Solvay Pharm Bv Derivados de benzooxazoles, composiciones farmaceuticas y su uso para el tratamiento de desordenes del sistema nervioso.
US7750013B2 (en) 2005-08-22 2010-07-06 Solvay Pharmaceuticals, B.V. N-oxides as prodrugs of piperazine and piperidine derivatives
US20070275977A1 (en) * 2006-05-02 2007-11-29 Van Aar Marcel P N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
US8106056B2 (en) 2006-06-16 2012-01-31 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and a dopamine agonist
CN101541797A (zh) 2006-12-07 2009-09-23 弗·哈夫曼-拉罗切有限公司 螺-哌啶衍生物
EP2102207B1 (de) 2006-12-07 2010-06-02 F.Hoffmann-La Roche Ag Spiropiperidinderivate als antagonisten des via-rezeptors
US8071622B2 (en) 2006-12-08 2011-12-06 Hoffman-La Roche Inc. Indoles
CN101547914A (zh) 2006-12-08 2009-09-30 弗·哈夫曼-拉罗切有限公司 吲哚类化合物
AU2007338115A1 (en) 2006-12-22 2008-07-03 F. Hoffmann-La Roche Ag Spiro-piperidine derivatives
CN101918382A (zh) * 2008-01-15 2010-12-15 雅培卫生保健产品有限责任公司 联苯芦诺衍生物
CN109890371A (zh) 2016-08-26 2019-06-14 斯瑞尼瓦萨饶·韦帕切杜 组合物及其方法
JP7186777B2 (ja) * 2018-07-27 2022-12-09 中国塗料株式会社 防汚塗料組成物、防汚塗膜、防汚塗膜付き基材及びその製造方法、並びに補修方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60126275A (ja) * 1983-12-13 1985-07-05 Otsuka Pharmaceut Co Ltd ベンゾチアゾ−ル誘導体
FR2567884B1 (fr) * 1984-07-19 1987-03-06 Roussel Uclaf Nouveaux derives de l'indole, leur preparation, leur application comme medicaments et les compositions les renfermant
DE3571436D1 (en) 1984-12-21 1989-08-17 Duphar Int Res New pharmaceutical compositions having anti-psychotic properties
ATE81975T1 (de) 1984-12-21 1992-11-15 Duphar Int Res Arzneimittel mit psychotroper wirkung.
WO1997036893A1 (en) * 1996-03-29 1997-10-09 Duphar International Research B.V. Piperazine and piperidine compounds
GB9811879D0 (en) * 1998-06-03 1998-07-29 Knoll Ag Therapeutic agents
UA71590C2 (en) * 1998-11-13 2004-12-15 Duphar Int Res Piperazine and piperidine derivatives
CA2405758A1 (en) * 2000-05-12 2001-11-15 Solvay Pharmaceuticals B.V. Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders
RU2261250C2 (ru) * 2000-05-12 2005-09-27 Солвей Фармасьютикалс Б.В. Соединения пиперазина и пиперидина

Also Published As

Publication number Publication date
US6911448B2 (en) 2005-06-28
DE60101386T2 (de) 2004-05-27
NO20025365D0 (no) 2002-11-08
CA2405971A1 (en) 2001-11-15
HK1055952A1 (en) 2004-01-30
MXPA02011084A (es) 2003-03-10
NZ522116A (en) 2004-04-30
CZ20023721A3 (cs) 2003-02-12
NO323778B1 (no) 2007-07-02
DE60101386D1 (de) 2004-01-15
SK286778B6 (sk) 2009-05-07
EP1283838A1 (de) 2003-02-19
RU2261250C2 (ru) 2005-09-27
AR028443A1 (es) 2003-05-07
IL152177A0 (en) 2003-05-29
SK15872002A3 (sk) 2003-04-01
CZ301464B6 (cs) 2010-03-10
US7297699B2 (en) 2007-11-20
BR0110592A (pt) 2003-04-01
IL152177A (en) 2009-08-03
EP1283838B1 (de) 2003-12-03
JP2003532729A (ja) 2003-11-05
NO20025365L (no) 2002-11-08
ZA200208537B (en) 2004-01-22
US20060089366A1 (en) 2006-04-27
DZ3370A1 (fr) 2001-11-15
WO2001085725A1 (en) 2001-11-15
ES2211809T3 (es) 2004-07-16
TR200302294T4 (tr) 2004-02-23
PL358201A1 (en) 2004-08-09
AU6392701A (en) 2001-11-20
US20030119849A1 (en) 2003-06-26
PT1283838E (pt) 2004-04-30
AU2001263927B2 (en) 2004-09-30
CN1174979C (zh) 2004-11-10
CN1429226A (zh) 2003-07-09
UA72337C2 (uk) 2005-02-15
DK1283838T3 (da) 2004-03-22
HUP0302016A2 (hu) 2003-09-29
PL198857B1 (pl) 2008-07-31
CA2405971C (en) 2010-03-30

Similar Documents

Publication Publication Date Title
NO20023787D0 (no) Piperazin- og piperidinderivater
DK1325008T3 (da) Piperazinderivater
ATE397595T1 (de) Piperazin-derivate
IS6546A (is) Nýjar píperazín afleiður
AR028343A1 (es) Derivados de pirrolidina y piperidina
DE60103472D1 (de) Rohrschneider
DE50105915D1 (de) Schutzhülle
NO20032585L (no) ABCA-1 forhoyende forbindelser
NO20026125L (no) Tetrahydropyridin- eller piperidin-heterocykliske derivater
DE60101386D1 (de) Piperazin- und piperidinverbindungen
DK1131308T3 (da) Piperazin- og piperidinderivater
NO20043079L (no) Piperazinderivat
NO20030276L (no) Fremgangsmåte
ITMI20000901A0 (it) Fluoroelastomeri
EE200300189A (et) Sillatud piperasiinderivaadid
NO20023954D0 (no) Substituerte piperasinforbindelser
ATE268757T1 (de) Piperidinalkohole
DE60109953D1 (de) Kapazitiver wandler
FR2805803B1 (fr) Monte-materiaux
DE60139781D1 (de) 4-substituierte piperidinverbindung
PT1131308E (pt) Novos compostos de piperazina e piperidina
FR2814381B1 (fr) Dechiqueteur
FI20001114A (fi) Kulmasuoja
DK1037892T3 (da) Piperidinderivater
ITMI20000805A0 (it) Lettino termale-estetico

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1283838

Country of ref document: EP